Syros Pharmaceuticals Inc (SYRS)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | -754k | 2.95M | 2.83M | 3.76M | 386k | 0 | 0 | 0 |
営業利益 | -36M | -33.21M | -34M | -34.26M | -27.51M | -30.92M | -27.42M | -26.18M |
税引前収入 | -4.77M | -23.79M | -36.26M | -40.14M | -64.38M | -3.71M | -23.33M | -6.4M |
純利益 | -4.77M | -23.79M | -36.26M | -40.14M | -64.38M | -3.71M | -23.33M | -6.4M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -36M | -33.21M | -34M | -34.26M | -27.51M | -30.92M | -27.42M | -26.18M |
EBITDA | -35.4M | -32.57M | -33.35M | -33.65M | -27.11M | -30.59M | -27.09M | -25.86M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 317k | 1.1M | 2.05M | 1.98M | 15.09M | 23.49M | 14.88M | 9.94M |
営業利益 | -47.96M | -54.69M | -64.3M | -77.74M | -82.3M | -99.42M | -135.87M | -128.99M |
税引前収入 | -47.74M | -54.01M | -62.28M | -75.44M | -84.04M | -86.56M | -94.65M | -164.57M |
純利益 | -51.42M | -54.01M | -62.28M | -75.44M | -84.04M | -86.56M | -94.65M | -164.57M |
優先配当 | -3.68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -2.199 | -2.044 | -1.844 | -1.739 | -1.495 | -1.396 | -4.671 | -7.812 |
EBIT | -47.74M | -54.01M | -62.28M | -75.44M | -82.3M | -99.42M | -135.87M | -128.99M |
EBITDA | -46.69M | -53.16M | -62.69M | -75.22M | -79.52M | -96.66M | -133.17M | -126.69M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約